litlas
Log inCreate account

Bob T. Li

Active 2015–2025

112
Papers
19,814
Citations
58
h-index
106
i10-index

Citations

Citations per year for Bob T. Li1993: 1 citations1999: 2 citations2000: 1 citations2004: 1 citations2010: 1 citations2015: 4 citations2016: 49 citations2017: 78 citations2018: 154 citations2019: 616 citations2020: 885 citations2021: 1,377 citations2022: 1,344 citations2023: 1,218 citations2024: 1,867 citations2025: 1,161 citations2026: 37 citations1994–1998: no citations, so these years are not shown2001–2003: no citations, so these years are not shown2005–2009: no citations, so these years are not shown2011–2014: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,993 citing papers, 26.9% of this breakdownChina: 1,466 citing papers, 13.2% of this breakdownItaly: 697 citing papers, 6.2% of this breakdownUnited Kingdom: 577 citing papers, 5.2% of this breakdownGermany: 486 citing papers, 4.4% of this breakdownFrance: 464 citing papers, 4.2% of this breakdownJapan: 444 citing papers, 4% of this breakdownSpain: 425 citing papers, 3.8% of this breakdownCanada: 308 citing papers, 2.8% of this breakdownNetherlands: 297 citing papers, 2.7% of this breakdownSwitzerland: 288 citing papers, 2.6% of this breakdownAustralia: 273 citing papers, 2.4% of this breakdown
0%26.9%Other 21.6%

Institutions

Fields

  • Medicine61%
  • Biochemistry, Genetics and Molecular Biology33.6%
  • Immunology and Microbiology1.8%
  • Computer Science0.7%
  • Chemistry0.6%
  • Engineering0.6%
  • Other1.7%

Topics

  • Lung Cancer Treatments and Mutations9.2%
  • Cancer Genomics and Diagnostics8.3%
  • Cancer Immunotherapy and Biomarkers5.6%
  • HER2/EGFR in Cancer Research3.8%
  • Lung Cancer Research Studies3.6%
  • Colorectal Cancer Treatments and Studies2.7%
  • Other66.8%

Coauthors

All papers

Open in search
  1. Sotorasib for Lung Cancers with KRAS p.G12C Mutation

    Authors: Ferdinandos Skoulidis, Bob T. Li, Grace K. Dy, Timothy Price, Gerald S. Falchook, Jürgen Wolf, Antoîne Italiano, Martin Schüler, Hossein Borghaei, Fabrice Barlési, Terufumi Kato, Alessandra Curioni‐Fontecedro, Adrian G. Sacher, Alexander I. Spira, Suresh S. Ramalingam, Toshiaki Takahashi, Benjamin Besse, Abraham Anderson, Agnes Ang, Qui Tran, Omar Mather, Haby Henary, Gataree Ngarmchamnanrith, Gregory Friberg, Vamsidhar Velcheti, Ramaswamy Govindan - New England Journal of Medicine 2021 cited by 1,769

  2. KRAS G12C Inhibition with Sotorasib in Advanced Solid Tumors

    Authors: David S. Hong, Marwan Fakih, John H. Strickler, Jayesh Desai, Gregory A. Durm, Geoffrey I. Shapiro, Gerald S. Falchook, Timothy Price, Adrian G. Sacher, Crystal S. Denlinger, Yung‐Jue Bang, Grace K. Dy, John C. Krauss, Yasutoshi Kuboki, James Kuo, Andrew L. Coveler, Keunchil Park, Tae Won Kim, Fabrice Barlési, Pamela N. Münster, Suresh S. Ramalingam, Timothy F. Burns, Funda Meric‐Bernstam, Haby Henary, Jude Ngang, Gataree Ngarmchamnanrith, June Myung Kim, Brett E. Houk, Jude Canon, J. Russell Lipford, Gregory Friberg, Piro Lito, Ramaswamy Govindan, Bob T. Li - New England Journal of Medicine 2020 cited by 1,687

  3. Trastuzumab Deruxtecan in HER2 -Mutant Non–Small-Cell Lung Cancer

    Authors: Bob T. Li, Egbert F. Smit, Yasushi Goto, Kazuhiko Nakagawa, Hibiki Udagawa, Julien Mazières, Misako Nagasaka, Lyudmila Bazhenova, Andreas Saltos, Enriqueta Felip, Jose M. Pacheco, M. Pérol, Luis Paz‐Ares, Kapil Saxena, Ryota Shiga, Yingkai Cheng, Suddhasatta Acharyya, Patrik Vitazka, Javad Shahidi, David Planchard, Pasi A. Jänne - New England Journal of Medicine 2021 cited by 980

  4. Diverse alterations associated with resistance to KRAS(G12C) inhibition

    Authors: Yulei Zhao, Yonina R. Murciano‐Goroff, Jenny Y. Xue, Agnes Ang, Jessica Lucas, Trang T. Mai, Arnaud Da Cruz Paula, Anne Y. Saiki, Deanna Mohn, Pragathi Achanta, Ann Elizabeth Sisk, Kanika Arora, Rohan S. Roy, Dong-Sung Kim, Chuanchuan Li, Lee P. Lim, Mark Li, Amber Bahr, Brian Houck‐Loomis, Elisa de Stanchina, Jorge S. Reis-Filho, Britta Weigelt, Michael F. Berger, Gregory J. Riely, Kathryn C. Arbour, J. Russell Lipford, Bob T. Li, Piro Lito - Nature 2021 cited by 447

  5. The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers

    Authors: Pedram Razavi, Matthew T. Chang, Guotai Xu, Chaitanya Bandlamudi, Dara S. Ross, Neil Vasan, Yanyan Cai, Craig M. Bielski, Mark T.A. Donoghue, Philip Jonsson, Alexander Penson, Ronglai Shen, Fresia Pareja, Ritika Kundra, Sumit Middha, Michael L. Cheng, Ahmet Zehir, Cyriac Kandoth, Ruchi Patel, Kety Huberman, Lillian M. Smyth, Komal Jhaveri, Shanu Modi, Tiffany A. Traina, Chau T. Dang, Wen Zhang, Britta Weigelt, Bob T. Li, Marc Ladanyi, David M. Hyman, Nikolaus Schultz, Mark E. Robson, Clifford A. Hudis, Edi Brogi, Agnès Viale, Larry Norton, Maura N. Dickler, Michael F. Berger, Christine A. Iacobuzio–Donahue, Sarat Chandarlapaty, Maurizio Scaltriti, Jorge S. Reis‐Filho, David B. Solit, Barry S. Taylor, José Baselga - Cancer Cell 2018 cited by 1,006

  6. EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer

    Authors: Vito Amodio, Rona Yaeger, Pamela Arcella, Carlotta Cancelliere, Simona Lamba, Annalisa Lorenzato, Sabrina Arena, Monica Montone, Benedetta Mussolin, Yu Bian, Adele Whaley, Marika Pinnelli, Yonina R. Murciano‐Goroff, Efsevia Vakiani, Nicola Valeri, Wei‐Li Liao, Anuja Bhalkikar, Sheeno Thyparambil, HuiYong Zhao, Elisa de Stanchina, Silvia Marsoni, Salvatore Siena, Andrea Bertotti, Livio Trusolino, Bob T. Li, Neal Rosen, Federica Di Nicolantonio, Alberto Bardelli, Sandra Misale - Cancer Discovery 2020 cited by 488

  7. High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants

    Authors: Pedram Razavi, Bob T. Li, David N. Brown, Byoungsok Jung, Earl Hubbell, Ronglai Shen, Wassim Abida, Krishna Juluru, Ino de Bruijn, Chenlu Hou, Oliver Venn, Raymond S. Lim, Aseem Anand, Tara Maddala, Sante Gnerre, Ravi Vijaya Satya, Qin‐Wen Liu, Ling Shen, Nicholas Eattock, Jeanne Yue, Alexander W. Blocker, Mark Lee, Amy J. Sehnert, Hui Xu, Megan P. Hall, Angie Santiago-Zayas, William Novotny, James M. Isbell, Valerie W. Rusch, George Plitas, Alexandra S. Heerdt, Marc Ladanyi, David M. Hyman, David R. Jones, Monica Morrow, Gregory J. Riely, Howard I. Scher, Charles M. Rudin, Mark E. Robson, Luis A. Díaz, David B. Solit, Alexander M. Aravanis, Jorge S. Reis‐Filho - Nature Medicine 2019 cited by 767

  8. Targeting KRAS in cancer

    Authors: Anupriya Singhal, Bob T. Li, Eileen M. O’Reilly - Nature Medicine 2024 cited by 272

  9. Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies

    Authors: Jarushka Naidoo, David B. Page, Bob T. Li, Louise C. Connell, Katja Schindler, Mario E. Lacouture, Michael A. Postow, Jedd D. Wolchok - Annals of Oncology 2015 cited by 1,463

  10. Inferring gene expression from cell-free DNA fragmentation profiles

    Authors: Mohammad Shahrokh Esfahani, Emily G. Hamilton, Mahya Mehrmohamadi, Barzin Y. Nabet, Stefan Alig, Daniel A. King, Chloé B. Steen, Charles Macaulay, André Schultz, Monica Nesselbush, Joanne Soo, Joseph G. Schroers‐Martin, Binbin Chen, Michael S. Binkley, Henning Stehr, Jacob J. Chabon, Brian J. Sworder, Angela BY Hui, Matthew J. Frank, Everett J. Moding, Chih Long Liu, Aaron M. Newman, James M. Isbell, Charles M. Rudin, Bob T. Li, David M. Kurtz, Maximilian Diehn, Ash A. Alizadeh - Nature Biotechnology 2022 cited by 213

  11. Targeting HER2 with Trastuzumab Deruxtecan: A Dose-Expansion, Phase I Study in Multiple Advanced Solid Tumors

    Authors: Junji Tsurutani, Hiroji Iwata, Ian E. Krop, Pasi A. Jänne, Toshihiko Doi, Shunji Takahashi, Haeseong Park, Charles H. Redfern, Kenji Tamura, Trisha M. Wise‐Draper, Kaku Saito, Masahiro Sugihara, Jasmeet Singh, Takahiro Jikoh, Gilles Gallant, Bob T. Li - Cancer Discovery 2020 cited by 353

  12. HER kinase inhibition in patients with HER2- and HER3-mutant cancers

    Authors: David M. Hyman, Sarina A. Piha‐Paul, Helen Won, Jordi Rodón, Cristina Saura, Geoffrey I. Shapiro, Dejan Juric, David I. Quinn, Víctor Moreno, Bernard Doger, Ingrid A. Mayer, Valentina Boni, Emiliano Calvo, Sherene Loi, A. Craig Lockhart, Joseph P. Erinjeri, Maurizio Scaltriti, Gary A. Ulaner, Juber Patel, Jiabin Tang, Hannah Beer, S. Duygu Selçuklu, Aphrothiti J. Hanrahan, Nancy Bouvier, Myra Melcer, Rajmohan Murali, Alison M. Schram, Lillian M. Smyth, Komal Jhaveri, Bob T. Li, Alexander Drilon, James J. Harding, Gopa Iyer, Barry S. Taylor, Michael F. Berger, Richard E. Cutler, Feng Xu, Anna Butturini, Lisa D. Eli, Grace Mann, Cynthia Farrell, Alshad S. Lalani, Richard Bryce, Carlos L. Arteaga, Funda Meric‐Bernstam, José Baselga, David B. Solit - Nature 2018 cited by 788

  13. HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

    Authors: Bob T. Li, Flavia Michelini, Sandra Misale, Emiliano Cocco, Laura Baldino, Yanyan Cai, Sophie Shifman, Hai‐Yan Tu, Mackenzie L. Myers, Chong‐Rui Xu, Marissa S. Mattar, Inna Khodos, Megan Little, Besnik Qeriqi, Gregory Weitsman, Clare J. Wilhem, Alshad S. Lalani, Irmina Diala, Rachel A. Freedman, Nancy U. Lin, David B. Solit, Michael F. Berger, Paul R. Barber, Tony Ng, Michael Offin, James M. Isbell, David R. Jones, Helena A. Yu, Sheeno Thyparambil, Wei‐Li Liao, Anuja Bhalkikar, Fabiola Cecchi, David M. Hyman, Jason S. Lewis, Darren J. Buonocore, Alan L. Ho, Vicky Makker, Jorge S. Reis‐Filho, Pedram Razavi, Maria E. Arcila, Mark G. Kris, John T. Poirier, Ronglai Shen, Junji Tsurutani, Gary A. Ulaner, Elisa de Stanchina, Neal Rosen, Charles M. Rudin, Maurizio Scaltriti - Cancer Discovery 2020 cited by 289

  14. Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial

    Authors: Bob T. Li, Ronglai Shen, Darren J. Buonocore, Zachary T. Olah, Ai Ni, Michelle S. Ginsberg, Gary A. Ulaner, Michael Offin, Daniel Feldman, Todd Hembrough, Fabiola Cecchi, Sarit Schwartz, Nick Pavlakis, Stephen Clarke, Helen Won, Edyta B. Brzostowski, Gregory J. Riely, David B. Solit, David M. Hyman, Alexander Drilon, Charles M. Rudin, Michael F. Berger, José Baselga, Maurizio Scaltriti, Maria E. Arcila, Mark G. Kris - Journal of Clinical Oncology 2018 cited by 559

  15. Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated KRAS G12C-Mutated Non–Small-Cell Lung Cancer: 2-Year Analysis of CodeBreaK 100

    Authors: Grace K. Dy, Ramaswamy Govindan, Vamsidhar Velcheti, Gerald S. Falchook, Antoîne Italiano, Jürgen Wolf, Adrian G. Sacher, Toshiaki Takahashi, Suresh S. Ramalingam, Christophe Dooms, Dong‐Wan Kim, Alfredo Addeo, Jayesh Desai, Martin Schüler, Pascale Tomasini, David S. Hong, Piro Lito, Qui Tran, Simon Jones, Abraham Anderson, Antreas Hindoyan, Wendy Snyder, Ferdinandos Skoulidis, Bob T. Li - Journal of Clinical Oncology 2023 cited by 149

  16. Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

    Authors: Justin Jee, Emily S. Lebow, Randy Yeh, Jeeban P. Das, Azadeh Namakydoust, Paul K. Paik, Jamie E. Chaft, Gowtham Jayakumaran, A. Rose Brannon, Ryma Benayed, Ahmet Zehir, Mark T.A. Donoghue, Nikolaus Schultz, Debyani Chakravarty, Ritika Kundra, Ramyasree Madupuri, Yonina R. Murciano‐Goroff, Hai‐Yan Tu, Chong‐Rui Xu, Andrés Martinez, Clare Wilhelm, Jesse Galle, Bobby Daly, Helena A. Yu, Michael Offin, Matthew D. Hellmann, Piro Lito, Kathryn C. Arbour, Marjorie G. Zauderer, Mark G. Kris, Kenneth Ng, Juliana Eng, Isabel R. Preeshagul, W. Victoria Lai, John J. Fiore, Afsheen N. Iqbal, Daniela Molena, Gaetano Rocco, Bernard J. Park, Lee P. Lim, Mark Junjie Li, Candace Tong-Li, Madhawa De Silva, David Chan, Connie I. Diakos, Malinda Itchins, Stephen Clarke, Nick Pavlakis, Adrian V. Lee, Natasha Rekhtman, Jason C. Chang, William D. Travis, Gregory J. Riely, David B. Solit, Mithat Gönen, Valerie W. Rusch, Andreas Rimner, Daniel R. Gomez, Alexander Drilon, Howard I. Scher, Sohrab P. Shah, Michael F. Berger, Maria E. Arcila, Marc Ladanyi, Ross L. Levine, Ronglai Shen, Pedram Razavi, Jorge S. Reis‐Filho, David R. Jones, Charles M. Rudin, James M. Isbell, Bob T. Li - Nature Medicine 2022 cited by 185

  17. Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial

    Authors: Egbert F. Smit, Enriqueta Felip, Dipesh Uprety, Misako Nagasaka, Kazuhiko Nakagawa, Luis Paz‐Ares, Jose M. Pacheco, Bob T. Li, David Planchard, Christina S. Baik, Yasushi Goto, Haruyasu Murakami, Andreas Saltos, Kaline Pereira, Ayumi Taguchi, Yingkai Cheng, Qi Yan, Wenqin Feng, Zenta Tsuchihashi, Pasi A. Jänne - The Lancet Oncology 2024 cited by 156

  18. First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study

    Authors: Ryan J. Sullivan, Jeffrey R. Infante, Filip Jankú, Deborah Jean Lee Wong, Jeffrey A. Sosman, Vicki L. Keedy, Manish R. Patel, Geoffrey I. Shapiro, James W. Mier, Anthony W. Tolcher, Andrea Wang‐Gillam, Mario Sznol, Keith T. Flaherty, Elizabeth I. Buchbinder, Richard D. Carvajal, Anna M. Varghese, Mario E. Lacouture, Antoni Ribas, Sapna P. Patel, Gary DeCrescenzo, Caroline M. Emery, Anna Groover, Saurabh Saha, Mary Varterasian, Dean J. Welsch, David M. Hyman, Bob T. Li - Cancer Discovery 2017 cited by 418

  19. Accelerating Discovery of Functional Mutant Alleles in Cancer

    Authors: Matthew T. Chang, Tripti Shrestha Bhattarai, Alison M. Schram, Craig M. Bielski, Mark T.A. Donoghue, Philip Jonsson, Debyani Chakravarty, Sarah Phillips, Cyriac Kandoth, Alexander Penson, Alexander N. Gorelick, Tambudzai Shamu, Swati Patel, Christopher Harris, Jianjiong Gao, S. Onur Sumer, Ritika Kundra, Pedram Razavi, Bob T. Li, Dalicia N. Reales, Nicholas D. Socci, Gowtham Jayakumaran, Ahmet Zehir, Ryma Benayed, Maria E. Arcila, Sarat Chandarlapaty, Marc Ladanyi, Nikolaus Schultz, José Baselga, Michael F. Berger, Neal Rosen, David B. Solit, David M. Hyman, Barry S. Taylor - Cancer Discovery 2017 cited by 426

  20. Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer

    Authors: Rona Yaeger, Riccardo Mezzadra, Jenna Sinopoli, Yu Bian, Michelangelo Marasco, Esther Kaplun, Yijun Gao, HuiYong Zhao, Arnaud Da Cruz Paula, Yingjie Zhu, Almudena Chaves Perez, Kalyani Chadalavada, Edison Tse, Sudhir Chowdhry, Sydney Bowker, Qing Chang, Besnik Qeriqi, Britta Weigelt, Gouri J. Nanjangud, Michael F. Berger, Hirak Der‐Torossian, Kenna Anderes, Nicholas D. Socci, Jinru Shia, Gregory J. Riely, Yonina R. Murciano‐Goroff, Bob T. Li, James G. Christensen, Jorge S. Reis‐Filho, David B. Solit, Elisa de Stanchina, Scott W. Lowe, Neal Rosen, Sandra Misale - Cancer Discovery 2022 cited by 138

  21. OA03.06 CodeBreaK 100/101: First Report of Safety/Efficacy of Sotorasib in Combination with Pembrolizumab or Atezolizumab in Advanced KRAS p.G12C NSCLC

    Authors: Bob T. Li, G.S. Falchook, G.A. Durm, T.F. Burns, Ferdinandos Skoulidis, Suresh S. Ramalingam, Alexander I. Spira, C.M. Bestvina, Sarah B. Goldberg, R. Veluswamy, W.T. Iams, A.A. Chiappori, C.R. Lemech, A.R. Meloni, V. Ebiana, Tao Dai, Diana Maria Gauto, Tracy Varrieur, W.J. Snyder, R. Govindan - Journal of Thoracic Oncology 2022 cited by 100

  22. Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)–related interstitial lung disease/pneumonitis—Focus on proactive monitoring, diagnosis, and management

    Authors: Sandra M. Swain, Mizuki Nishino, Lisa Lancaster, Bob T. Li, Andrew G. Nicholson, Brian J. Bartholmai, Jarushka Naidoo, Eva Schumacher-Wulf, Kohei Shitara, Junji Tsurutani, PierFranco Conte, Terufumi Kato, Fabrice André, Charles A. Powell - Cancer Treatment Reviews 2022 cited by 167

  23. Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies

    Authors: Emmet Jordan, Hyunjae R. Kim, Maria E. Arcila, David Barron, Debyani Chakravarty, Jianjiong Gao, Matthew T. Chang, Ai Ni, Ritika Kundra, Philip Jonsson, Gowtham Jayakumaran, Sizhi Paul Gao, Hannah C. Johnsen, Aphrothiti J. Hanrahan, Ahmet Zehir, Natasha Rekhtman, Michelle S. Ginsberg, Bob T. Li, Helena A. Yu, Paul K. Paik, Alexander Drilon, Matthew D. Hellmann, Dalicia N. Reales, Ryma Benayed, Valerie W. Rusch, Mark G. Kris, Jamie E. Chaft, José Baselga, Barry S. Taylor, Nikolaus Schultz, Charles M. Rudin, David M. Hyman, Michael F. Berger, David B. Solit, Marc Ladanyi, Gregory J. Riely - Cancer Discovery 2017 cited by 662

  24. Tumor Mutation Burden and Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with EGFR -Mutant Lung Cancers

    Authors: Michael Offin, Hira Rizvi, Megan Tenet, Ai Ni, Francisco Sánchez-Vega, Bob T. Li, Alexander Drilon, Mark G. Kris, Charles M. Rudin, Nikolaus Schultz, Maria E. Arcila, Marc Ladanyi, Gregory J. Riely, Helena A. Yu, Matthew D. Hellmann - Clinical Cancer Research 2018 cited by 334